Ching Yan Chu

No ORCID on file · 5 papers in corpus · active 2008-2025

Study types

  • article 3
  • other 2

Condition tags

  • endometriosis 5
other 2025
Correction: Receptor tyrosine kinase inhibitor sunitinib as novel immunotherapy to inhibit myeloid-derived suppressor cells for treatment of endometriosis
Frontiers in immunology ·doi:10.3389/fimmu.2025.1741271

[This corrects the article DOI: 10.3389/fimmu.2021.641206.].

article 2021
Receptor Tyrosine Kinase Inhibitor Sunitinib as Novel Immunotherapy to Inhibit Myeloid-Derived Suppressor Cells for Treatment of Endometriosis
Frontiers in immunology ·doi:10.3389/fimmu.2021.641206

Endometriosis is a common, benign, and hormone-dependent gynaecological disorder that displays altered immunoinflammatory profiles. Myeloid-derived suppressor cells (MDSCs) suppressed immunosurveillance in endometriosis in human and mouse m…

article 2012
Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice
Angiogenesis ·doi:10.1007/s10456-012-9299-4
other 2011
Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo
Fertility and sterility ·doi:10.1016/j.fertnstert.2011.07.008

OBJECTIVE: To investigate the antiangiogenesis mechanism of epigallocatechin-3-gallate (EGCG) in an endometriosis model in vivo. DESIGN: Animal studies. SETTING: University laboratory. ANIMAL(S): Human endometrium from women with endomet…

article 2008
Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model
Human Reproduction ·doi:10.1093/humrep/den417

BACKGROUND: The development of new blood vessels plays an essential role in growth and survival of endometriosis. Epigallocatechin gallate (EGCG) from green tea has powerful anti-angiogenic properties and our aim was to evaluate these prope…